Skip to main content
SpringerLink
Log in

Bee venom allergy immunotherapy

Anaphylaxis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Boni E, et al. Dose-dependence of protection from systemic reactions to venom immunotherapy by omalizumab. Clinical and Molecular Allergy 14: No. 14, 24 Oct 2016. Available from: URL: http://doi.org/10.1186/s12948-016-0051-2 - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bee venom allergy immunotherapy. Reactions Weekly 1630, 32 (2016). https://doi.org/10.1007/s40278-016-23556-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-23556-x

Search

Navigation